Professional
Added to YB: 2025-09-23
Pitch date: 2025-09-20
SOFW.TA [neutral]
SofWave Medical Ltd.
+39.5%
current return
Author Info
No bio for this author
Company Info
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally.
Market Cap
ILS 454.7M
Pitch Price
ILS 24.99
Price Target
N/A
Dividend
N/A
EV/EBITDA
96.56
P/E
646.00
EV/Sales
5.58
Sector
Health Care Equipment and Supplies
Category
growth
Arauca Capital Portfolio Holding: SofWave Medical Ltd.
SOFW.TA (holding update): Q2 revs $21M (+43% YoY), first IFRS profit $1.5M, cash-flow positive. Recurring revs $9.2M (+53% YoY) = 43% of sales. GLP-1 weight-loss drug tailwind creating new demand for skin tightening as fat reduction/fillers decline. 63% GLP-1 patients new to aesthetics. 34% share of voice online.
Read full article (2 min)